Effectiveness of sofosbuvir/pegylated-interferon plus ribavirin in treatment of hepatitis C virus genotype 4 patients

INTRODUCTION: New regimens involving direct-acting antiviral agents (DAAs) have recently been approved for the treatment of hepatitis C virus (HCV) genotype 4 (GT4). The current study aims to assess the efficacy and safety of sofosbuvir (SOF) with pegylated interferon (PegINF)/ribavirin (RBV) for ch...

詳細記述

保存先:
書誌詳細
出版年:Clin Exp Hepatol
主要な著者: Abdel-Moneim, Adel, Abood, Alaa, Abdel-Gabaar, Mohamed, Zanaty, Mohamed I., Ramadan, Mohamed
フォーマット: Artigo
言語:Inglês
出版事項: Termedia Publishing House 2018
主題:
Original Paper
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6185926/
https://ncbi.nlm.nih.gov/pubmed/30324144
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/ceh.2018.78123
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料